Compare AMRX & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | PBI |
|---|---|---|
| Founded | 2002 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 1.6B |
| IPO Year | N/A | N/A |
| Metric | AMRX | PBI |
|---|---|---|
| Price | $12.20 | $10.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $13.25 | $11.67 |
| AVG Volume (30 Days) | 1.7M | ★ 2.8M |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 3.13% |
| EPS Growth | N/A | N/A |
| EPS | 0.02 | ★ 0.45 |
| Revenue | ★ $2,934,959,000.00 | $1,931,125,000.00 |
| Revenue This Year | $9.99 | N/A |
| Revenue Next Year | $6.67 | N/A |
| P/E Ratio | $647.64 | ★ $24.24 |
| Revenue Growth | ★ 9.50 | N/A |
| 52 Week Low | $6.69 | $6.88 |
| 52 Week High | $12.68 | $13.11 |
| Indicator | AMRX | PBI |
|---|---|---|
| Relative Strength Index (RSI) | 58.30 | 57.18 |
| Support Level | $11.87 | $9.70 |
| Resistance Level | $12.43 | $10.26 |
| Average True Range (ATR) | 0.32 | 0.23 |
| MACD | -0.06 | 0.11 |
| Stochastic Oscillator | 48.96 | 96.27 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal worksharing discounts. It derives maximum revenue from SendTech Solutions.